Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 11 | 2025 | 438 | 2.960 |
Why?
|
| Nasal Cavity | 5 | 2020 | 57 | 2.390 |
Why?
|
| Bacteria | 7 | 2023 | 521 | 2.200 |
Why?
|
| Corynebacterium | 3 | 2025 | 13 | 1.580 |
Why?
|
| Nasal Mucosa | 2 | 2025 | 90 | 1.320 |
Why?
|
| Biofilms | 4 | 2014 | 93 | 1.200 |
Why?
|
| Staphylococcus aureus | 4 | 2025 | 482 | 1.090 |
Why?
|
| Genome, Bacterial | 2 | 2025 | 204 | 1.000 |
Why?
|
| Phylogeny | 4 | 2025 | 693 | 0.940 |
Why?
|
| Microbial Interactions | 3 | 2023 | 15 | 0.840 |
Why?
|
| Organoids | 1 | 2025 | 304 | 0.730 |
Why?
|
| Metagenome | 3 | 2012 | 139 | 0.720 |
Why?
|
| Streptococcus pneumoniae | 3 | 2025 | 389 | 0.710 |
Why?
|
| Carnobacteriaceae | 1 | 2020 | 2 | 0.660 |
Why?
|
| Hair Follicle | 1 | 2020 | 31 | 0.660 |
Why?
|
| Nasopharynx | 1 | 2020 | 86 | 0.630 |
Why?
|
| Bacterial Infections | 2 | 2020 | 323 | 0.630 |
Why?
|
| DNA Restriction-Modification Enzymes | 1 | 2019 | 2 | 0.610 |
Why?
|
| Cytokines | 1 | 2025 | 1336 | 0.600 |
Why?
|
| Listeria monocytogenes | 2 | 2010 | 30 | 0.580 |
Why?
|
| Skin | 2 | 2020 | 543 | 0.510 |
Why?
|
| Respiratory Tract Infections | 2 | 2017 | 295 | 0.500 |
Why?
|
| Symbiosis | 1 | 2016 | 71 | 0.480 |
Why?
|
| Antibiosis | 1 | 2016 | 14 | 0.470 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2016 | 112 | 0.460 |
Why?
|
| Computational Biology | 1 | 2020 | 868 | 0.440 |
Why?
|
| Coproporphyrins | 1 | 2014 | 1 | 0.430 |
Why?
|
| Propionibacterium | 1 | 2014 | 4 | 0.430 |
Why?
|
| Bacillus subtilis | 2 | 2008 | 43 | 0.430 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 254 | 0.420 |
Why?
|
| Escherichia coli | 1 | 2019 | 995 | 0.390 |
Why?
|
| Triglycerides | 1 | 2016 | 606 | 0.390 |
Why?
|
| Oropharynx | 2 | 2010 | 31 | 0.340 |
Why?
|
| Peptide Termination Factors | 1 | 2010 | 16 | 0.320 |
Why?
|
| Respiratory System | 2 | 2025 | 96 | 0.290 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2020 | 379 | 0.280 |
Why?
|
| Genomics | 4 | 2025 | 1623 | 0.270 |
Why?
|
| Flagella | 1 | 2007 | 26 | 0.260 |
Why?
|
| DNA, Bacterial | 2 | 2019 | 484 | 0.250 |
Why?
|
| Disease Susceptibility | 2 | 2018 | 278 | 0.240 |
Why?
|
| Bacterial Proteins | 2 | 2010 | 940 | 0.240 |
Why?
|
| Movement | 1 | 2007 | 144 | 0.240 |
Why?
|
| Pneumococcal Infections | 2 | 2020 | 279 | 0.240 |
Why?
|
| Biosynthetic Pathways | 1 | 2025 | 32 | 0.220 |
Why?
|
| Botswana | 1 | 2024 | 76 | 0.220 |
Why?
|
| Anti-Bacterial Agents | 5 | 2021 | 2565 | 0.220 |
Why?
|
| Humans | 18 | 2025 | 130870 | 0.210 |
Why?
|
| Corynebacterium Infections | 1 | 2023 | 5 | 0.210 |
Why?
|
| Nose | 1 | 2024 | 114 | 0.200 |
Why?
|
| Biological Products | 1 | 2025 | 141 | 0.190 |
Why?
|
| Pharyngitis | 1 | 2021 | 34 | 0.170 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2020 | 832 | 0.170 |
Why?
|
| Epithelial Cells | 1 | 2025 | 903 | 0.170 |
Why?
|
| Propionibacterium acnes | 1 | 2020 | 13 | 0.170 |
Why?
|
| Sigma Factor | 1 | 2001 | 36 | 0.170 |
Why?
|
| Chromosome Segregation | 1 | 2001 | 68 | 0.160 |
Why?
|
| Chromosomes, Bacterial | 1 | 2001 | 64 | 0.160 |
Why?
|
| Integrases | 1 | 2001 | 157 | 0.150 |
Why?
|
| Child, Preschool | 5 | 2021 | 15018 | 0.150 |
Why?
|
| Infant | 4 | 2021 | 13299 | 0.150 |
Why?
|
| Species Specificity | 1 | 2020 | 482 | 0.150 |
Why?
|
| Genetic Techniques | 1 | 2019 | 96 | 0.140 |
Why?
|
| Bayes Theorem | 1 | 2020 | 308 | 0.140 |
Why?
|
| Bacterial Adhesion | 2 | 2010 | 104 | 0.140 |
Why?
|
| DNA Replication | 1 | 2001 | 362 | 0.140 |
Why?
|
| Streptococcal Infections | 1 | 2021 | 251 | 0.140 |
Why?
|
| Plasmids | 1 | 2019 | 451 | 0.140 |
Why?
|
| Candida albicans | 1 | 2018 | 88 | 0.130 |
Why?
|
| Mutation | 4 | 2010 | 6140 | 0.120 |
Why?
|
| Triolein | 1 | 2016 | 3 | 0.120 |
Why?
|
| Hydrolysis | 1 | 2016 | 140 | 0.120 |
Why?
|
| Carrier State | 1 | 2016 | 81 | 0.110 |
Why?
|
| Clostridium Infections | 1 | 2018 | 249 | 0.110 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 84 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 1722 | 0.110 |
Why?
|
| Metagenomics | 1 | 2015 | 115 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2014 | 325 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2015 | 597 | 0.100 |
Why?
|
| Feces | 2 | 2018 | 722 | 0.100 |
Why?
|
| Age Factors | 2 | 2017 | 2842 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 1977 | 0.090 |
Why?
|
| Biota | 1 | 2012 | 6 | 0.090 |
Why?
|
| Palatine Tonsil | 1 | 2012 | 34 | 0.090 |
Why?
|
| Pharynx | 1 | 2012 | 64 | 0.090 |
Why?
|
| Mouth | 1 | 2012 | 64 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2015 | 386 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2001 | 2454 | 0.080 |
Why?
|
| Biodiversity | 1 | 2010 | 72 | 0.080 |
Why?
|
| Probiotics | 1 | 2012 | 226 | 0.080 |
Why?
|
| Temperature | 1 | 2010 | 289 | 0.080 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2010 | 169 | 0.070 |
Why?
|
| United States | 1 | 2024 | 11865 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2010 | 177 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2015 | 1555 | 0.070 |
Why?
|
| Centrifugation | 1 | 2007 | 19 | 0.070 |
Why?
|
| Glass | 1 | 2007 | 9 | 0.070 |
Why?
|
| Cystic Fibrosis | 1 | 2010 | 266 | 0.060 |
Why?
|
| Glycosylation | 1 | 2007 | 126 | 0.060 |
Why?
|
| Adhesins, Bacterial | 1 | 2007 | 74 | 0.060 |
Why?
|
| Adolescent | 4 | 2021 | 20820 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 3497 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2017 | 8509 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 1995 | 73 | 0.050 |
Why?
|
| Multigene Family | 1 | 2025 | 291 | 0.050 |
Why?
|
| Middle Aged | 2 | 2017 | 28517 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2023 | 364 | 0.040 |
Why?
|
| Child | 3 | 2021 | 26218 | 0.040 |
Why?
|
| Rec A Recombinases | 1 | 2001 | 27 | 0.040 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2001 | 20 | 0.040 |
Why?
|
| Female | 4 | 2018 | 70560 | 0.040 |
Why?
|
| Recombinases | 1 | 2001 | 28 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2023 | 364 | 0.040 |
Why?
|
| Dimerization | 1 | 2001 | 138 | 0.040 |
Why?
|
| Streptococcus pyogenes | 1 | 2021 | 84 | 0.040 |
Why?
|
| United Kingdom | 1 | 2021 | 257 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 130 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 2001 | 216 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 308 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 422 | 0.040 |
Why?
|
| Aged | 1 | 2017 | 20974 | 0.040 |
Why?
|
| Cecum | 1 | 2018 | 26 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 694 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2001 | 569 | 0.030 |
Why?
|
| Models, Biological | 1 | 2023 | 1391 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2018 | 126 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2001 | 716 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 836 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1501 | 0.030 |
Why?
|
| Confidentiality | 1 | 2015 | 107 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1994 | 40 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 1995 | 237 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1995 | 229 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1995 | 348 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1210 | 0.020 |
Why?
|
| Adult | 2 | 2012 | 31245 | 0.020 |
Why?
|
| Veillonellaceae | 1 | 2012 | 1 | 0.020 |
Why?
|
| Genes, rRNA | 1 | 2012 | 19 | 0.020 |
Why?
|
| Bacteroidetes | 1 | 2012 | 21 | 0.020 |
Why?
|
| Actinobacteria | 1 | 2012 | 11 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2015 | 750 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 2012 | 98 | 0.020 |
Why?
|
| Saliva | 1 | 2012 | 125 | 0.020 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2010 | 48 | 0.020 |
Why?
|
| Ecosystem | 1 | 2010 | 91 | 0.020 |
Why?
|
| Pseudomonas Infections | 1 | 2010 | 117 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 4716 | 0.020 |
Why?
|
| Male | 2 | 2012 | 64772 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 4683 | 0.020 |
Why?
|
| Polyenes | 2 | 1995 | 2 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 1995 | 49 | 0.010 |
Why?
|
| Androstadienes | 2 | 1995 | 50 | 0.010 |
Why?
|
| Protein Kinase C | 2 | 1995 | 112 | 0.010 |
Why?
|
| Genotype | 1 | 2010 | 2606 | 0.010 |
Why?
|
| Enzyme Activation | 2 | 1995 | 582 | 0.010 |
Why?
|
| Sirolimus | 2 | 1995 | 231 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 1995 | 343 | 0.010 |
Why?
|
| Lung | 1 | 2010 | 1550 | 0.010 |
Why?
|
| Animals | 3 | 2018 | 33982 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 10042 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1995 | 58 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1995 | 37 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 1994 | 16 | 0.010 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1994 | 18 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1995 | 105 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1994 | 121 | 0.010 |
Why?
|
| Tacrolimus | 1 | 1995 | 102 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 1994 | 63 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1995 | 159 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1995 | 812 | 0.010 |
Why?
|
| Signal Transduction | 2 | 1995 | 4697 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1995 | 1580 | 0.010 |
Why?
|
| Cell Line | 1 | 1994 | 2580 | 0.000 |
Why?
|
| Insulin | 1 | 1994 | 1148 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1995 | 2907 | 0.000 |
Why?
|
| Mice | 2 | 1995 | 18268 | 0.000 |
Why?
|